Gallid herpesvirus 3 (ATCC® VR-2176)

Classification: Herpesviridae, Mardivirus  /  Product Format: frozen

Permits and Restrictions

View Permits

Classification Herpesviridae, Mardivirus
Agent Gallid herpesvirus 3
Strain 301B/1
Applications
Must be preserved in living cells to maintain viability (10% DMSO).
Must be preserved in living cells to maintain viability (10% DMSO).
Biosafety Level 2
Product Format frozen
Storage Conditions -196C
Comments
Must be preserved in living cells to maintain viability (10% DMSO). Vaccine strain.
Effect on Host
Cytopathic effects in tissue culture
Recommended Host
primary and secondary chicken embryo fibroblasts
Growth Conditions
Incubation: 3 days
Effect on Host
Cytopathic effects in tissue culture
Name of Depositor RL Witter
References

Witter RL. Serotype 2 Marek's disease vaccine. US Patent 4,895,718 dated Jan 23 1990

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customer Acceptance of Responsibility, ATCC Form 62 required for distribution.
  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
  • USDA APHIS VS 16-6 or 16-6A permit must be obtained and a copy of the permit must be sent to ATCC in advance of shipment. The Application Form VS 16-3 (Import controlled material import or transport organisms or vectors) must be submitted to USDA APHIS Veterinary Services to obtain the VS 16-6 or 16-6A permit.
Basic Documentation